©2012 Baishideng Publishing Group Co.
World J Clin Oncol. Apr 10, 2012; 3(4): 57-62
Published online Apr 10, 2012. doi: 10.5306/wjco.v3.i4.57
Published online Apr 10, 2012. doi: 10.5306/wjco.v3.i4.57
Table 2 Patient characteristics
| Pt | Pathology/site/stage | HD | ID | ED | Plan | ||
| 1 | SCC | Oropharynx | T3N3 | 70 | 56 | VMAT | |
| 2 | SCC | Larynx | T4N0 | 70 | 63 | 56 | VMAT |
| 3 | SCC | Oropharynx | T2N2A | 70 | 60 | VMAT | |
| 4 | SCC | Larynx | T3N2B | 66 | 66 | VMAT | |
| 5 | SCC | Larynx | T3N2C | 70 | 56 | VMAT | |
| 6 | SCC | Oropharynx | T2N2B | 70 | 56 | VMAT | |
| 7 | SCC | Oropharynx | T3N0 | 70 | 56 | VMAT | |
| 8 | SCC | Larynx | T4N2C | 70 | 56 | VMAT | |
| 9 | SCC | Nasopharynx | T1N3 | 70 | 60 | 55 | VMAT |
| 10 | SCC | Oropharynx | T1N1 | 66 | 56 | VMAT | |
| 11 | SCC | Larynx | T3N0 | 70 | 56 | VMAT | |
| 12 | Medullary | Thyroid | T4bN1b | 66 | 66 | VMAT | |
| 13 | SCC | Oropharynx | T4N2C | 70 | 63 | VMAT | |
| 14 | SCC | Oropharynx | T2N2C | 70 | 56 | VMAT | |
| 15 | SCC | Hypopharynx | T2N3 | 70 | 56 | VMAT | |
| 16 | SCC | Oropharynx | T2N3 | 70 | 60 | VMAT | |
| 17 | SCC | Larynx | T3N0 | 70 | 56 | IMRT | |
| 18 | SCC | Oropharynx | T3N2C | 70 | 56 | IMRT | |
| 19 | SCC | Oropharynx | T3N2B | 70 | 56 | VMAT | |
| 20 | SCC | Oropharynx | T2N1 | 70 | 56 | VMAT | |
-
Citation: Fung-Kee-Fung SD, Hackett R, Hales L, Warren G, Singh AK. A prospective trial of volumetric intensity-modulated arc therapy
vs conventional intensity modulated radiation therapy in advanced head and neck cancer. World J Clin Oncol 2012; 3(4): 57-62 - URL: https://www.wjgnet.com/2218-4333/full/v3/i4/57.htm
- DOI: https://dx.doi.org/10.5306/wjco.v3.i4.57